Health Catalyst, Inc.
NASDAQ:HCAT · NASDAQ Global Select
-$0.04 today
Vol 1.96M · Avg 1.24M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-53.60%
Period High
$4.09
Period Low
$1.00
Latest
$1.74
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Prelude Therapeutics Incorporated
NASDAQ:PRLD
$329.69M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$293.93M
Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
$233.55M
Caribou Biosciences, Inc.
NASDAQ:CRBU
$158.69M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$127.03M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$118.77M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$118.47M
Solana Company
NASDAQ:HSDT
$94.00M
Outset Medical, Inc.
NASDAQ:OM
$87.68M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$78.81M
What is the latest HCAT filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does HCAT have?
Intrinsic Alpha currently shows 20 recent filings for HCAT.
Explore More
Continue the stock analysis
Jump to another research area for this company.